Diaceutics Plc (DXRX) Ord GBP0.002
- Add to watchlist
- Create an alert
- This stock can be held in a
103.50p
103.65p
109.00p
£87.64 million
103.00p
103.00p
80.50p
119.77
1.00p (0.96%) Previous:
1.00p
19,733
n/a
3,000
Performance
Not available for this stock.
Fundamental data
Year ending: | 31/12/2022 | 31/12/2021 |
---|---|---|
Revenue (£m) | 19.50 | 13.94 |
Profit before tax (£m) | 0.56 | 0.46 |
Adjusted EPS (p): | 0.86 | 0.67 |
P/E ratio | 87.80 | 152.20 |
PEG | 3.10 | n/a |
EPS growth (%) | 28.00 | (10.00) |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Diaceutics appoints new VP of marketing
9 April 2024 12:34
-
Director dealings: BAT, Diaceutics execs make investments
6 June 2023 13:47
-
Diaceutics shares resume trading after HSBC buys SVB UK
13 March 2023 11:10
-
Appointment of Amie Mc Neice as VP of Marketing
9 April 2024 07:00
-
Block Listing Return
5 April 2024 13:40
-
PDMR Shareholding/Share Incentive Plan
3 April 2024 07:00
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.